Adax

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Adax

Quick Facts

Property Description
Active ingredient Alprazolam
Form Tablet (Standard and Sustained-Release)
Pharmacological class Benzodiazepine (Triazolobenzodiazepine)
General purpose Relieving nervous tension (Anxiolytic)
Origin Synthetic

What is Adax and What Type of Medicine is It?

Adax is a prescription-only medication whose active ingredient is the synthetic compound Alprazolam. This single-ingredient product is classified within the benzodiazepine pharmacological class, specifically known as a triazolobenzodiazepine. This classification identifies it as a powerful Central Nervous System (CNS) depressant that affects the brain's internal signaling systems. Alprazolam has a characteristically rapid onset of action compared to many other agents in the benzodiazepine family and is utilized in the management of anxiety states.

Adax Formulations: Tablets and Sustained-Release Types

Adax is designed for oral administration and is available in two distinct dosage forms: standard tablets and specialized sustained-release tablets, often referred to as ADAX RETARD. The standard form ensures a rapid entry of Alprazolam into the system, which is a key differentiating factor for immediate use. Conversely, the sustained-release tablet is deliberately formulated using solid pharmaceutical excipients to control the drug's release over an extended period. The existence of both standard and prolonged-release options provides flexibility in achieving a steady therapeutic profile.

What is the General Purpose of This Anxiolytic?

The general purpose of Adax is to function as a potent anxiolytic, aimed at relieving nervous tension and symptoms of agitation. It achieves this by boosting the effects of GABA (gamma-aminobutyric acid), the brain's main inhibitory neurotransmitter. By acting as a positive allosteric modulator at the GABA-A receptor, Alprazolam enhances this natural system, resulting in a decrease in excessive neuronal signaling and promoting a fundamental state of mental and physical calmness.

Regulatory References

  1. NIH StatPearls: Alprazolam

What side effects are possible with Adax?

Adax (lisdexamfetamine) is a prescription medication that carries risks of side effects, ranging from common and generally mild to rare but serious. Patients should be closely monitored by a healthcare professional throughout treatment.

Common Side Effects

The most frequently reported side effects, affecting more than one in ten people, include:

  • Dry mouth
  • Decreased appetite and weight loss
  • Trouble sleeping (insomnia)
  • Headache

Other common effects can include anxiety, dizziness, irritability, nausea, stomach pain, vomiting, diarrhea, and constipation.


Serious Safety Information and Warnings

Cardiovascular Risks: Adax is a stimulant and may increase blood pressure and heart rate. It has been associated with sudden death, stroke, and heart attack in adults, especially those with pre-existing heart problems. Children and adolescents with serious heart defects or other severe heart problems should not typically use this medication. Patients should be evaluated for heart disease before starting treatment.

Psychiatric Symptoms: This medication can cause new or worsen existing psychiatric symptoms. This may include new or worsened psychosis, mania, aggression, or hostile behavior. New psychotic or manic symptoms, such as hallucinations or delusional thinking, can occur in children and adolescents, even without a prior history.

Serotonin Syndrome: A rare but serious condition, Serotonin Syndrome, may occur, particularly when Adax is taken with other medicines that increase serotonin. Symptoms can include agitation, hallucinations, fever, muscle stiffness, fast heart rate, and severe nausea or vomiting. Immediate medical attention is required if these symptoms develop.

Circulation Problems (Raynaud’s Phenomenon): Adax may cause blood circulation problems in the fingers and toes, causing them to feel numb, cool, or painful. The skin may change color (pale, blue, or red).

Overdose and Emergency Response

Overdose and When to Seek Help

An overdose of Adax (Alprazolam) is officially documented to present a spectrum of Central Nervous System (CNS) depression symptoms. These manifestations, listed in regulatory prescribing information, include somnolence, confusion, impaired coordination, diminished reflexes, and slurred speech. The most severe outcomes documented are coma and death, with the risk significantly amplified by the co-ingestion of other CNS depressants, particularly alcohol or opioid medications.

The official guidance strictly mandates that immediate emergency medical attention must be sought upon suspicion of overdose. Urgent help is required if the person exhibits signs of profound intoxication, such as being hard to wake up, significantly slowed or shallow breathing, or signs of airway distress.

Management, as described in regulatory documents, centers on comprehensive supportive care and close observation. This may include necessary procedures like assisted ventilation for severe respiratory depression. While the antagonist Flumazenil is available to reverse benzodiazepine effects, its use is often not recommended for routine overdose reversal due to specific regulatory concerns about precipitating seizure activity. Furthermore, certain populations, including geriatric patients and those with hepatic or renal impairment, may experience a prolonged duration of overdose effects.

Therapeutic Uses of Adax

What Adax Treats: Main Uses and Benefits

Adax (Alprazolam) is commonly used to provide short-term symptomatic support across specific therapeutic areas characterized by heightened physiological stress and increased discomfort or tension. The medicine is considered relevant for managing Generalized Anxiety Disorder and Panic Disorder in adults. The use is generally associated with providing support that helps ease the overall symptom burden and may assist with maintaining functional stability.

Key Therapeutic Focus

Adax is applied in addressing symptom clusters related to chronic psychological strain, such as excessive worry, constant restlessness, and heightened irritability. It is commonly used to help with addressing symptom clusters related to heightened physiological activity, such as overwhelming intense fear and severe physical symptoms like palpitations and muscle tension. This supportive action may assist with managing distress and supports the patient during difficult episodes by easing distress.


Quick Fact: Therapeutic Focus in Acute Contexts

Symptom Domain Conditions Key Benefit
Excessive Worry, Intense Fear Generalized Anxiety Disorder, Panic Disorder May assist with managing symptoms that interfere with daily comfort
Physical Symptoms Muscle tension, Palpitations, Sleep disturbance Supports the patient during difficult episodes by easing distress

Eligibility and Restrictions for Use

Who Can and Cannot Use Adax?

This section outlines the official population eligibility and non-eligibility rules for Adax (Alprazolam) as determined by governmental regulatory bodies, such as the U.S. FDA and European agencies. Eligibility is strictly limited to specific populations and conditions.


Official Eligibility Status

Classification Population or Condition
Approved Population Adults are the only age group for whom Adax is indicated.
Use Not Established Pediatric patients (under 18); safety and effectiveness have not been established.
Conditional Use Geriatric patients and those with hepatic impairment require a restricted, lower starting dosage.

Absolute Contraindications

Adax must not be used by the following groups:

  • Patients with known hypersensitivity to alprazolam or other benzodiazepines.
  • Patients with acute narrow-angle glaucoma.
  • Patients concurrently taking strong CYP3A inhibitors (e.g., ketoconazole or itraconazole).

Reproductive Status Restrictions

Use is not recommended during pregnancy due to the potential risk of Neonatal Sedation and Withdrawal Syndrome (NOWS). Use is also not recommended while breastfeeding, as the drug is present in human milk and may cause adverse reactions in the infant.

What should I know about interactions with other medicines?

Adax Interactions with other medicines and products

Adax is the proprietary name for alprazolam, a substance that interacts significantly with other medicines primarily through the hepatic enzyme system cytochrome P450 3A (CYP3A). The majority of documented and clinically relevant interactions relate to agents that either inhibit or induce this metabolic pathway.


Interacting Medicinal Products and Categories

Product Class or Category Interaction Mechanism / Resulting Effect
Central Nervous System (CNS) Depressants Additive depressant effects, increasing the risk of profound sedation, respiratory depression, coma, and death. Includes opioids, alcohol, sedating antihistamines, and other benzodiazepines.
Strong CYP3A Inhibitors Decrease the metabolism of Adax, significantly raising its plasma concentration (e.g., Ketoconazole, Itraconazole). Co-administration with most strong inhibitors is officially contraindicated.
CYP3A Inducers Increase the metabolism of Adax, leading to decreased plasma concentrations and potentially reduced clinical effectiveness. Includes products like Carbamazepine.
Ritonavir A specific potent CYP3A inhibitor where official labeling dictates mandatory dose adjustments and timing-based constraints (e.g., dosage reduction when starting concomitant therapy).
Digoxin May increase the concentration of Digoxin, raising the risk of toxicity.

Official Interaction Constraints

Patients should avoid the co-administration of Adax with alcohol and are explicitly cautioned against the combination of Adax with opioid-containing products due to the serious risks to the central nervous and respiratory systems. Concomitant use with strong CYP3A inhibitors is generally prohibited. The overall interaction profile is defined by pharmacokinetic changes mediated by the CYP3A enzyme, alongside pharmacodynamic effects when combined with other CNS depressants.

Mechanism of Action

How Adax Works


Modulating the Brain's Primary Inhibitory System

The mechanism of Adax centers on Positive Allosteric Modulation (PAM) of the GABA-A receptor complex, which constitutes the brain's main inhibitory signaling system. This action enhances the natural inhibitory effect of the neurotransmitter GABA by increasing the frequency of chloride ion channel opening upon GABA binding. This results in the hyperpolarization of the neuron and a generalized reduction in the excitability of nerve cells.


Systemic and Regional Signaling Modulation

Due to the widespread distribution of GABA-A receptors, this enhanced inhibition initiates a generalized neural slowing across the central nervous system (CNS). The modulation is particularly significant in the limbic system, the region responsible for processing emotions and arousal signals. This focused suppression of activity within limbic circuits contributes to the resulting physiological consequence of diminished arousal. The broad CNS effect also manifests as reduced skeletal muscle tension and the promotion of somnolence.

Dosage and Administration Information

How to Use Adax (Sapropterin Dihydrochloride)

This section outlines the administration guidelines for Adax, detailing the standard procedures for its use.

Route of Administration and Dosing

Adax is for oral administration only. The typical starting dose for adults and pediatric patients (1 month and older) is 10 mg/kg of actual body weight, taken once daily. The dose is adjusted by a healthcare provider based on the individual's biochemical response, within a range of 5 mg/kg to 20 mg/kg per day.

Preparation and Timing

The medication must be taken with a meal to optimize absorption. The tablet or powder must be dissolved in a specified volume of liquid—typically 4 to 8 ounces of water or apple juice—before ingestion. For the powder, the solution must be taken within 30 minutes of preparation, while the tablet solution must be consumed within 15 minutes. Adax use must be coupled with the required Phenylalanine (Phe)-restricted diet as defined by the prescribing physician.

Procedural Rules and Monitoring

If a dose is missed, it should be taken as soon as possible, but two doses must not be taken on the same day. Treatment is procedural: a patient’s blood phenylalanine levels are monitored for up to one month at a specific dose to determine if they are a responder. If there is no satisfactory decrease in blood Phe after this trial period, established protocols indicate that the treatment be discontinued.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Adax (Alprazolam)

The research available for Adax monitored short-term symptom patterns in adults. Findings describe group patterns related to specific anxiety conditions, but research provides context but not individual predictions. Evidence highlights what is known—and what is still uncertain—about this agent.


Evidence for Use in Generalized Anxiety Disorder (GAD)

Research examined the use of Adax through short-term, placebo-controlled trials in adults who met diagnostic criteria for GAD. These studies primarily focused on monitoring changes in the intensity of GAD symptoms over defined time intervals, generally up to four months.

The outcomes measured were related to the core symptoms of the condition, such as excessive worry and constant restlessness. Research monitored changes measured during the study period using standardized assessment tools.

What remains uncertain is the long-term characterization of these outcomes. The primary data for GAD is restricted to short-term studies, meaning there is limited information for long-term outcomes regarding the continued symptomatic profile of the condition.


Evidence for Use in Panic Disorder (PD)

Adax was evaluated in studies involving adults with Panic Disorder. Research for this indication included Randomized Controlled Trials (RCTs) for both the standard tablet and the sustained-release formulation (ADAX RETARD).

Findings from trials describe symptom patterns, but comparative evidence with other standard benzodiazepine treatments indicates that results were sometimes mixed. Furthermore, some studies for the sustained-release form of Adax have been associated with reports of publication bias, which means the available evidence quality varies across studies.

Outcomes and Trial Duration in PD

The typical follow-up durations for the controlled efficacy trials in Panic Disorder were limited, often lasting only 4 to 10 weeks. Research describes patterns related to short-term changes during the treatment phase but does not fully establish the long-term effects, particularly upon discontinuation.


Evidence in Special Populations

The majority of clinical research was observed in adult patients aged 18 to 65. Data for certain groups remain insufficient:

  • Older Adults: While Adax was evaluated in older patients, research observed patterns associated with increased sensitivity in this population.
  • Children and Adolescents: Evidence is limited for the pediatric population.
  • Comorbid Conditions: Studies monitored responses in patients with co-occurring health issues, but results apply only to the populations studied in the primary trials.

Key Studies & References

  1. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials (Source for GAD short-term data, trial duration, and publication bias mention)
  2. Review: Drug for panic disorder less effective than previously believed (Source for publication bias specifically regarding extended-release alprazolam/ADAX RETARD)
  3. Alprazolam - StatPearls - NCBI Bookshelf (Source for general clinical use, special populations, and caution in older adults)

Frequently Asked Questions (FAQ)

Common questions about Adax (FAQ)


Q: How quickly should I expect Adax to start working?

According to official product information, the active ingredient in Adax reaches its highest concentration in the bloodstream relatively quickly, typically within one to two hours after taking the immediate-release tablet. This time frame reflects how quickly the active substance is detected in the body.


Q: Does taking Adax require any special diet changes?

Regulatory documents state that Adax must be taken with food or a meal to help optimize its absorption into the body. Official labeling emphasizes taking it with food, and no other specific, broad dietary restrictions are typically noted.


Q: Why does the official documentation mention 'use with caution' for Adax?

Official documentation notes caution due to several risks, including the potential for profound sedation and respiratory depression when Adax is combined with other central nervous system (CNS) depressants. Additionally, the drug carries regulatory warnings concerning the risks of dependence, misuse, and addiction.


Q: What is the typical duration of treatment with Adax?

Clinical trials that established the effectiveness of Adax for Generalized Anxiety Disorder (GAD) were generally short, lasting up to four months. Due to the risks of dependence and withdrawal, official prescribing guidelines emphasize that the need for continued treatment must be frequently reassessed by a healthcare provider. The primary clinical studies supporting its use focused on short-term outcomes.


Q: What happens if I miss a day of taking Adax?

The official patient information provides guidance for a missed dose. Official product information states that if a dose is missed, the dose may be taken when remembered, but it is explicitly noted that two doses must not be taken at the same time.


Q: Are there any known interactions between Adax and common pain relievers?

Official labeling specifically includes a serious warning against using Adax in combination with opioid pain relievers. This combination can lead to an additive depressant effect, which significantly increases the risk of profound sedation, respiratory depression, coma, and death.


Q: Does Adax affect fertility or reproductive health?

Adax use is not recommended during pregnancy. Regulatory data states that use may be associated with an increased risk of Neonatal Sedation and Withdrawal Syndrome (NOWS) in the newborn. Additionally, non-clinical animal studies have indicated that the active ingredient may have the potential to impair fertility.


Q: How is Adax used in older adults?

Adax can be used by older adults. However, official regulatory guidance specifies that a lower starting dosage is utilized for patients in this population. This is due to observed increased sensitivity to the medication, which can lead to a greater risk of adverse effects like drowsiness and impaired coordination.


Q: How is Adax used for patients with liver problems?

Patients with severe liver impairment (hepatic impairment) require careful consideration and a lower starting dosage as specified in official documents. Because the drug is processed by the liver, a lower starting dosage is specified to manage the medication's concentration in the body.


Q: Can Adax be taken indefinitely, or is treatment usually short-term?

Clinical research has been limited to short-term studies, meaning information about the outcomes of very long-term use is restricted. Due to the inherent risk of physical dependence and withdrawal associated with this class of medicine, regulatory bodies emphasize that the need for treatment must be reassessed frequently.


Q: How is Adax different from a supplement?

Adax is fundamentally different from a supplement because it is a prescription-only medication. It is classified as a Schedule IV controlled substance by regulatory bodies and requires the authorization of a licensed healthcare provider before it can be dispensed.


Q: What kind of research has been done on Adax in pregnant patients?

Official data and studies collected on pregnant patients suggest that the use of Adax may be associated with an increased risk of Neonatal Sedation and Withdrawal Syndrome (NOWS) in the newborn. This data forms the basis for the official recommendation against its use during pregnancy.


Q: What does 'contraindicated' mean in the context of Adax?

A contraindication is a strict, official warning from regulatory bodies that dictates that the medical treatment must not be used under certain conditions because of the clear potential for harm. For Adax, this includes conditions like acute narrow-angle glaucoma or co-administration with strong CYP3A inhibitors.


Q: Does Adax require special monitoring (like blood tests)?

Official labeling does not require routine blood tests for all patients taking Adax. However, healthcare providers routinely assess and monitor the patient for the risk of abuse, misuse, or addiction, in addition to any changes in mood or behavior throughout the treatment period.


Q: What happens if Adax doesn't seem to be working for me?

Official guidelines describe that dosage adjustments or treatment discontinuation are procedures determined by the healthcare provider when the patient’s clinical response is assessed as inadequate. Any changes to the treatment plan are based on the provider's professional assessment of the individual's needs.


Q: Are there any common long-term side effects reported for Adax?

While most clinical studies are short-term, long-term use has been associated with effects such as weight changes and an increased risk of physical dependence and withdrawal reactions. The development of liver problems has also been noted in clinical experience, although this is considered uncommon.


Q: Does Adax have a risk of dependence or withdrawal symptoms?

Yes, Adax carries a regulatory Boxed Warning concerning the risk of physical dependence and withdrawal reactions. Official information states that abrupt discontinuation of the drug, particularly after long-term use, can lead to severe and potentially life-threatening withdrawal symptoms.


Q: Does Adax interact with herbal supplements like St. John's Wort?

Regulatory documents caution against combining Adax with certain herbal products, such as St. John’s Wort. This is because they can increase the body's metabolism of the drug, potentially resulting in lower drug concentrations in the bloodstream and reducing its intended clinical effect.


Q: What unusual changes require immediate medical attention while taking Adax?

Official patient counseling information describes signs of severe reactions, such as swelling of the face or throat, which require immediate medical attention. The labeling also notes that symptoms like suicidal thoughts, new psychiatric symptoms (such as hallucinations), or any sudden severe change in behavior are reported and should be brought to the attention of a healthcare provider promptly.


Q: Is Adax available as a generic medicine?

Yes, according to the FDA's product listings, the active ingredient in Adax, alprazolam, is officially available in multiple FDA-approved generic tablet formulations produced by various manufacturers.


Q: How does Adax fit into a full treatment plan for my condition?

Adax is indicated for the acute treatment of Generalized Anxiety Disorder (GAD) and the treatment of Panic Disorder. Regulatory agencies define it as a single pharmaceutical component used within a comprehensive treatment strategy for these conditions.


Q: Is Adax known to cause any skin reactions or rashes?

Official documents note that certain reactions may occur. Skin rashes, itching, and severe allergic reactions known as angioedema (swelling beneath the skin) have been reported in the post-marketing experience with this medication.


Q: Does Adax have a warning regarding sunlight exposure?

The official labeling does not list a specific warning regarding photosensitivity (increased sensitivity to sunlight). However, some medications in the same class have been associated with increased sensitivity to sunlight, though this is considered a rare occurrence.


Q: Is Adax used to treat pain or a chronic condition?

Adax is classified as an anxiolytic, and its official indications are for anxiety and panic disorders, which may be experienced as chronic conditions. It is not indicated for the treatment of pain.


Q: Why is Adax not recommended for people with kidney disease?

Official labeling states that usual precautions are observed in treating patients with impaired renal function (kidney disease). The drug's processing suggests caution, though specific contraindications related to kidney disease are not typically noted.


Q: How soon after stopping Adax does it leave the body?

Official pharmacokinetic data indicates that the elimination half-life of the active ingredient typically ranges from 6 to 27 hours in healthy adults. The actual time it takes to fully clear the drug from the body can vary widely depending on individual factors.


Q: Does Adax affect hormone levels?

Research associated with regulatory review indicates that the active ingredient may affect certain neuroendocrine responses. Specifically, studies have examined its effects on levels of Luteinizing Hormone (LH) and the stress hormone cortisol.


Q: Are there different strengths of Adax available?

Yes, the official 'How Supplied' section of the product labeling indicates that the standard immediate-release tablets are available in multiple dosage strengths, commonly including 0.25 mg, 0.5 mg, 1 mg, and 2 mg.


Q: Why is Adax sometimes prescribed with a combination of other medicines?

Adax may be used as part of a comprehensive treatment strategy determined by a healthcare provider. This combination use is intended to address the full spectrum of symptoms related to anxiety or panic disorder more effectively than Adax used alone.

How should Adax be stored and disposed of?

How to Store and Dispose of Adax?

The official storage and disposal requirements for Adax (Alprazolam) are strictly defined by regulatory guidance to maintain product integrity and ensure public safety.

Official Storage Conditions

Requirement Specific Instruction
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F).
Protection Keep in a tightly closed container, away from excessive heat, moisture, direct light, and freezing.
Security The medicine must be kept out of the sight and reach of children in a secure location due to its controlled substance classification.

Disposal Requirements

Unused or expired Adax must be disposed of promptly and safely. The primary official method is to use a DEA-authorized drug take-back program or an authorized collection site. If these options are unavailable, the medicine can be disposed of in household trash by mixing it with an unappealing substance, but it must not be flushed down the toilet or poured down the drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Adax found in:

A-Z Index: